The use of intravenous tyramine and the cold pressor test to help elucidate a possible mechanism of action of a new isoquinoline compound shown to have antihypertensive properties in humans

Clinical Trial

R Pocelinko et al. Int Z Klin Pharmakol Ther Toxikol. 1969 Jan.

. 1969 Jan;2(1):13-9.

No abstract available

Similar articles

Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
Pettinger WA, Korn A, Spiegel H, Solomon HM, Pocelinko R, Abrams WB. Pettinger WA, et al. Clin Pharmacol Ther. 1969 Sep-Oct;10(5):667-74. doi: 10.1002/cpt1969105667. Clin Pharmacol Ther. 1969. PMID: 5808462 No abstract available.
Effect of debrisoquin, guanethidine and tyramine on platelet function and blood coagulation.
Zbinden G, Tomlin S. Zbinden G, et al. Arch Int Pharmacodyn Ther. 1969 Sep;181(1):153-69. Arch Int Pharmacodyn Ther. 1969. PMID: 5350778 No abstract available.
Pharmacological actions of N-(2-o-methoxyphenoxyethyl)-6,7-dimethoxy-3,4-dihydro-2-(1H)-isoquinoline carboxamidine hydrobromide (SC-3123).
Ferrini R, Miragoli G, Santarelli G. Ferrini R, et al. Boll Chim Farm. 1972 Jun;111(6):353-65. Boll Chim Farm. 1972. PMID: 4403255 No abstract available.
[Possibilities and limitations in the diagnosis of pheochromocytoma].
Lachhein L, Schütz J. Lachhein L, et al. Z Gesamte Inn Med. 1969 May 1;24(9):257-62. Z Gesamte Inn Med. 1969. PMID: 4898355 Review. German. No abstract available.
Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects.
Bianchetti MG, Minder I, Beretta-Piccoli C, Meier A, Weidmann P. Bianchetti MG, et al. Klin Wochenschr. 1982 May 3;60(9):465-70. doi: 10.1007/BF01720361. Klin Wochenschr. 1982. PMID: 7045511 Review.